INTERIM RESULTS OF A DOUBLE-BLIND, RANDOMIZED PHASE 2 STUDY OF THE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE PLUS TENOFOVIR DISOPROXIL FUMARATE, AND ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B SUBJECTS WITH DECOMPENSATED LIVER DISEASE
dc.contributor.author | Liaw, Yun-Fan | |
dc.contributor.author | Lee, Chuan-Mo | |
dc.contributor.author | Akarca, Ulus S. | |
dc.contributor.author | George, Papatheodoridis V. | |
dc.contributor.author | Wong, Florence | |
dc.contributor.author | Chang, Ting-Tsung | |
dc.contributor.author | Horban, Andrzej | |
dc.contributor.author | Wang, Chia C. | |
dc.contributor.author | Kwan, Peter | |
dc.contributor.author | Buti, Maria | |
dc.contributor.author | Prieto, Martin | |
dc.contributor.author | Berg, Thomas | |
dc.contributor.author | Kitrinos, Kathryn M. | |
dc.contributor.author | Sorbel, Jeff | |
dc.contributor.author | Mondou, Elsa | |
dc.contributor.author | Frederick, David | |
dc.contributor.author | Rousseau, Franck | |
dc.contributor.author | Schiff, Eugene R. | |
dc.date.accessioned | 2019-10-27T20:48:58Z | |
dc.date.available | 2019-10-27T20:48:58Z | |
dc.date.issued | 2009 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 30-NOV 03, 2009 -- Boston, MA | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 410A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 409A | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/42795 | |
dc.identifier.volume | 50 | en_US |
dc.identifier.wos | WOS:000270456000223 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | John Wiley & Sons Inc | en_US |
dc.relation.ispartof | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | INTERIM RESULTS OF A DOUBLE-BLIND, RANDOMIZED PHASE 2 STUDY OF THE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE, EMTRICITABINE PLUS TENOFOVIR DISOPROXIL FUMARATE, AND ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B SUBJECTS WITH DECOMPENSATED LIVER DISEASE | en_US |
dc.type | Conference Object | en_US |